Guson Kang, MD
Interventional Cardiology · Stanford, CANPI 1033485057
Payments from drug & device makers
What this record shows
This record is dominated by grants: $18,055 of the $29,523 with a category attached, or 61.2%. Medtronic accounts for 61.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $19,111 and has fallen 87.8% since, to $2,332 in 2025.
Across 87 payments — averaging $339.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$18K
- Abbott$6K
- Edwards Lifesciences$3K
- Cathworks, Inc.$625
- Shockwave Medical, Inc$600
- E.r. Squibb & Sons, L.L.C.$500
- plus $800 from 8 others
What the payments were for
- Consulting fees$3,13811%
- Speaking & faculty fees$5002%
- Grants$18,05561%
- Travel & lodging$4,56015%
- Food & beverage$3,27111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 3 | $18,057 |
| Abbott | 40 | $6,204 |
| Edwards Lifesciences | 24 | $2,738 |
| Cathworks, Inc. | 1 | $625 |
| Shockwave Medical, Inc | 1 | $600 |
| E.r. Squibb & Sons, L.L.C. | 1 | $500 |
| Boston Scientific | 8 | $410 |
| Inspire Medical Systems, Inc. | 1 | $178 |
| Abiomed | 3 | $104 |
| Cardiva Medical, Inc. | 1 | $43 |
| W. L. Gore & Associates, Inc. | 1 | $32 |
| Terumo Medical Corporation | 1 | $15 |
| Penumbra, Inc. | 1 | $12 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,523 in reported general payments places this provider in the 75th percentile of 585 interventional cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Stanford
- Rahul SharmaStanford$1M
- Jennifer TremmelStanford$233K
- David LeeStanford$231K
- Todd BrintonStanford$150K
- Matthew Pricela Jolla$2.3M
- Frederick St GoarMountain View$2.2M
- Saibal KarThousand Oaks$1.1M
- Puneet KhannaRancho Mirage$1M
- Dennis SheehanRedwood City$900K
- Suhail DohadBeverly Hills$802K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.